Robotic arm operating over a laboratory instrument in a dark environment
On-Demand Webinar

Lab Automation in Practice

How to plan, prioritize and scale successfully

Webinar summary

In this expert roundtable, David Heinz from ZEISS Digital Innovation discusses lab automation with Robbert van Putten from Johnson & Johnson and Jeff van Doren from Takeda. The conversation explores how automation projects can be scoped, prioritized and designed in R&D and QC environments. Viewers gain practical perspectives on ROI, standardization, data integration, validation, compliance, scalability and the organizational realities behind successful lab automation initiatives.

Key Takeaways

  • Start with a clear capacity bottleneck when possible: capacity-driven projects make it easier to define ROI, track progress and build credibility for further automation.
  • Do not start with the most complex or most attractive automation idea; the experts recommend beginning with a relatively simple pilot that is likely to work and can build organizational trust.
  • Standardization is a prerequisite for scalability: tube types, containers, labware, methods, interfaces and data formats can determine whether an automation workflow can be transferred across labs or sites.
  • User requirements, IT, EHS, procurement, validation and compliance should be involved early, because late-stage changes can slow down or derail implementation.
  • Lab automation is not only about cost savings; value can also come from improved data integrity, fewer deviations, better turnaround times, workload leveling, ergonomics and reduced paper-based work.
  • Data integration and open interfaces are central to scalable automation, especially when devices, LIMS, chromatography systems and software platforms need to work together.

The experts take a pragmatic view of automation trends: industrial automation principles, standardization and robust interfaces are seen as more relevant than hype around humanoid or mobile robots. 

Watch the webinar now

  • Lab Automation in Practice

    Runtime: 60 min.

Speakers in this webinar

Image of Dr. Robbert van Putten
Johnson & Johnson Innovative Medicine Dr. Robbert van Putten Scientific Manager Next-gen Experimentation

Robbert van Putten is Scientific Manager Next-Gen Experimentation at Johnson & Johnson Innovative Medicine. His work focuses on lab automation, high-throughput experimentation, robotics, data integration and self-driving labs.He previously held senior scientist roles in process R&D and high-throughput experimentation at J&J. With an academic background in chemical engineering, catalysis and automated reaction technology, he bridges scientific research and digital lab transformation. Today, he contributes to the development of data-driven, automated research environments in the life sciences.

Image of Jeff van Doren
Takeda Jeff van Doren Global Analytical Instrument Lifecycle Management Lead

Jeff Van Doren is Global Analytical Instrument Lifecycle Management Lead and Lab of the Future Lead at Takeda. He has 25+ years of experience in pharma, with a focus on vaccine and method development, automation, robotics and analytical instrument lifecycle management. His work centers on translating lab digitalization and advanced technologies into measurable business value. He is involved in Lab of the Future initiatives, including practical approaches to automation, technology deployment and scalable innovation. Jeff also contributes to industry discussions around connected labs, instrument connectivity and cross-functional lab transformation.

Image of David Heinz
ZEISS Digital Innovation Dr. David Heinz Business Development Manager

Dr. David Heinz is a Business Development Manager at ZEISS Digital Innovation, focusing on the digitalization and automation of pharmaceutical and life science laboratories. He specializes in integrating data, systems, and AI-driven approaches to enable connected, data-centric R&D processes. Prior to ZEISS, he held leadership roles in biotech, driving the development and scaling of innovative products and business units.

FAQs

  • Typical challenges include unclear objectives, non-scalable technical designs, late stakeholder involvement, missing standardization and difficulties in justifying ROI. In QC and GMP environments, additional challenges include regulatory impact, validation, space constraints, budget, vendor support and container or labware variability. The discussion also highlights that automation projects can become overly complex if teams try to automate too much too early.

  • The experts recommend starting with a clearly defined problem, preferably a capacity bottleneck where value and ROI are easier to track. Rather than beginning with the largest or most complex project, teams should choose a manageable use case that is likely to succeed and can build credibility. The discussion also emphasizes going into the lab, observing current workflows and challenging requirements before designing the automated process.

  • Lab Automation can create value through capacity gains, throughput improvements, reduced manual effort, better data quality, improved compliance, fewer deviations, reduced paper-based work, better turnaround times and improved ergonomics. The experts note that cost savings are often the easiest value to put into a business case, but they are not the only relevant KPI.

  • Standardization is one of the main prerequisites for scalable Lab Automation. Differences in tube types, containers, labware, methods, devices and data formats can limit transferability between labs or sites. The experts describe standardization as especially difficult in brownfield labs, but also point out that automation can help enforce more consistent processes over time.

  • Many lab automation projects are ultimately also data projects. Automated systems generate data that needs to be transferred into established software environments such as LIMS or chromatography data systems. The experts discuss the importance of open interfaces, APIs, software development kits and non-proprietary data formats to support integration and reduce repeated custom driver development.

  • In QC and GMP environments, validation and compliance must be addressed from the beginning. Jeff van Doren explains that global validation and compliance teams are involved in user requirements before purchase. The discussion also touches on audit trails, comparability studies and the need to understand whether a robot performing a task changes the regulatory impact compared with a human performing the same task.

  • The experts point to industrial automation principles, modularity, open interfaces, standardization and stronger data integration as important future directions. They are more cautious about highly visible technologies such as humanoid robots or mobile robots where the practical problem is unclear. Agentic AI for robotic automation is mentioned as an experimental area in R&D, while QC remains constrained by validation and compliance requirements.

Let’s work together

Fill out the form below to schedule a consultation with our experts

Form is loading...

If you want to have more information on data processing at ZEISS, please refer to our data protection notice.

Share this page

Contact

Write to us!

We are happy to answer your questions when you contact us using the contact form.

Form is loading...

Optional information

If you want to have more information on data processing at ZEISS, please refer to our data privacy notice.